[22] This might be related to III/IV glioma patients with high expression of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, 1p19q co-deletion, isocitrate dehydrogenase (IDH) gene mutations [23]. The gene discussed is IDH3A; the disease is glioma.